Seroreactivity of purified Brugia malayi microfilarial...

6
Indian Journal of Experimental Biology Vol. 38, August 2000, pp. 791-796 Seroreactivity of purified Brugia malayi microfilarial soluble and excretory- secretory antigens in different clinical presentations of bancroftian filariasis R Alii, Y P Bhandari, M V R Reddy* & B C Harinath Department of Biochemistry & JB Tropical Disease Research Centre, MGIMS, Sevagram (Wardha) 442102 , India Received 30 November /999; revised 27 April 2000 Brugia malayi microfilarial excretory-secretory (mf ES) and phosphate buffer saline soluble (mf S) antigens were fractionated by fast protein liquid chromatography (FPLC) on superdex 200 HR 10130 gel filtration column. The active antigen fractions were identified and explored in comparison with whole mf ES and mf S antigens to detect filarial JgG antibodies in different groups viz microfilaraemics, acute, chronic and occult filarial cases of Wuchereria bancrofti infection and endemic and non-endemic normals. One of the fractions of mf ES antigen (ESF-6) and two fractions of mf S antigen (SF-2 & 3) were identified to be useful to detect filarial antibodies. A pooled preparation of these antigen fractions gave a sensitivity of 86.6% (for microfilaraemic cases) and a specificity of 95% to detect filarial IgG antibodies by indirect ELISA. The pooled FPLC purified mf antigens also showed 55-88% of cases of different grades of clinical filariasis and 65% of tropical pulmonary eosinophilia cases as positive for filarial antibodies. The pooled FPLC purified B. malayi mf antigens with higher specificity are preferable to whole mf ES and mf S antigens to detect active filarial infection in microfilaraemia and as well in different clinical entities of bancroftian filariasis. One of the essential requirements for the effective management of lymphatic filariasis is the availability of a suitable diagnostic test, which could be useful for detection of active in individual cases, determining the level of endemicity and evaluation and monitoring of control programmes. The conventional diagnostic approach based on identification of microfilariae in night blood smear is inconvenient and not sensitive enough to detect low microfilaraemics1,2. Moreover microfilariae are not usually seen in the peripheral circulation in acute, chronic and occult filariasis 3 Immunodiagnostic assays based on detection of parasite antigens or antibodies against them in circulation have been developed3.4. Filarial antigen assays are suggested to be superior to the assays based on detection of filarial antibodies for indication of current infection 5 . While filarial antigen assays are quite useful to detect microfilaraemics, they usually gave negative results for amicrofilaraemic subjects with clinical fila- riasis 5 - 7 Filarial antibodies, on the other hand, have been detected across the clinical spectrum of filariasis 8 - lo and the specific antibody assays were found to be useful to detect and monitor the disease in acute, chronic and occult· filarial cases 3 . Brugia malayi microfilarial antigens have been reported to be *Correspondent author. potentially useful in the detection of Wuchereria b .-r." l' 1112 I h . . ancroJtl InlectlOn .. n t e present commumcatlOn, we have fractionated B. malayi mf excretory- secretory (ES) and phosphate buffer saline (PBS) soluble antigens, identified active fractions and explored their diagnostic use in different clinical presentations of bancroftian filariasis. Materials and Methods Human sera-Blood samples were collected from 30 microfilaraemic and 65 clinical filarial cases in Sevagram and surrounding villages in Maharashtra (India), which are endemic for nocturnally periodic W. bancrofti. The presence of mf was checked in the finger prick blood samples collected at night between 21.00 and 24.00 hours. The chronic filarial cases grouped as described earlier l3 included 25 of grade I (with acute episodes of filarial lymphangitis, lymphadenitis with or without fever or oedema for 1 to 3 months), 20 of grade 11 (with oedema or hydroceles for 2 to 5 years, several acute episodes of lymphangitis) and 20 of grade III (with established elephantiasis or hydrocele for. lO to 30 years). The occult filariasis group consisted of 20 cases of tropical pulmonary eosinophilia (TPE). Circulating microfilaria were not found in any of the patients with clinical filariasis. Blood samples were also collected from 30 healthy individuals (endemic

Transcript of Seroreactivity of purified Brugia malayi microfilarial...

Indian Journal of Experimental Biology Vol. 38, August 2000, pp. 791-796

Seroreactivity of purified Brugia malayi microfilarial soluble and excretory­secretory antigens in different clinical presentations of bancroftian filariasis

R Alii, Y P Bhandari, M V R Reddy* & B C Harinath

Department of Biochemistry & JB Tropical Disease Research Centre, MGIMS, Sevagram (Wardha) 442102, India

Received 30 November /999; revised 27 April 2000

Brugia malayi microfilarial excretory-secretory (mf ES) and phosphate buffer saline soluble (mf S) antigens were fractionated by fast protein liquid chromatography (FPLC) on superdex 200 HR 10130 gel filtration column. The active antigen fractions were identified and explored in comparison with whole mf ES and mf S antigens to detect filarial JgG antibodies in different groups viz microfilaraemics, acute, chronic and occult filarial cases of Wuchereria bancrofti infection and endemic and non-endemic normals. One of the fractions of mf ES antigen (ESF-6) and two fractions of mf S antigen (SF-2 & 3) were identified to be useful to detect filarial antibodies. A pooled preparation of these antigen fractions gave a sensitivity of 86.6% (for microfilaraemic cases) and a specificity of 95% to detect filarial IgG antibodies by indirect ELISA. The pooled FPLC purified mf antigens also showed 55-88% of cases of different grades of clinical filariasis and 65% of tropical pulmonary eosinophilia cases as positive for filarial antibodies. The pooled FPLC purified B. malayi mf antigens with higher specificity are preferable to whole mf ES and mf S antigens to detect active filarial infection in microfilaraemia and as well in different clinical entities of bancroftian filariasis.

One of the essential requirements for the effective management of lymphatic filariasis is the availability of a suitable diagnostic test, which could be useful for detection of active infecti~n in individual cases, determining the level of endemicity and evaluation and monitoring of control programmes. The conventional diagnostic approach based on identification of microfilariae in night blood smear is inconvenient and not sensitive enough to detect low microfilaraemics1,2. Moreover microfilariae are not usually seen in the peripheral circulation in acute, chronic and occult filariasis3

• Immunodiagnostic assays based on detection of parasite antigens or antibodies against them in circulation have been developed3.4. Filarial antigen assays are suggested to be superior to the assays based on detection of filarial antibodies for indication of current infection5

. While filarial antigen assays are quite useful to detect microfilaraemics, they usually gave negative results for amicrofilaraemic subjects with clinical fila­riasis5

-7

• Filarial antibodies, on the other hand, have been detected across the clinical spectrum of filariasis8

-lo and the specific antibody assays were

found to be useful to detect and monitor the disease in acute, chronic and occult· filarial cases3

. Brugia malayi microfilarial antigens have been reported to be

*Correspondent author.

potentially useful in the detection of Wuchereria b .-r." l' • 1112 I h . . ancroJtl InlectlOn .. n t e present commumcatlOn, we have fractionated B. malayi mf excretory­secretory (ES) and phosphate buffer saline (PBS) soluble antigens, identified active fractions and explored their diagnostic use in different clinical presentations of bancroftian filariasis.

Materials and Methods Human sera-Blood samples were collected from

30 microfilaraemic and 65 clinical filarial cases in Sevagram and surrounding villages in Maharashtra (India), which are endemic for nocturnally periodic W. bancrofti. The presence of mf was checked in the finger prick blood samples collected at night between 21.00 and 24.00 hours. The chronic filarial cases grouped as described earlier l3 included 25 of grade I (with acute episodes of filarial lymphangitis, lymphadenitis with or without fever or oedema for 1 to 3 months), 20 of grade 11 (with oedema or hydroceles for 2 to 5 years, several acute episodes of lymphangitis) and 20 of grade III (with established elephantiasis or hydrocele for. lO to 30 years) . The occult filariasis group consisted of 20 cases of tropical pulmonary eosinophilia (TPE). Circulating microfilaria were not found in any of the patients with clinical filariasis. Blood samples were also collected from 30 healthy individuals (endemic

792 INDIAN J EXP BIOL, AUGUST 2000

normals) who had lived in endemic region for over five years and had no history of filariasis and 10 healthy individuals (non-end~mic normals) who stay in filarial nonendemic areas (states of Jammu & Kashmir, Haryana, Punjab and Himachal Pradesh in India). Sera were separated and stored at -20°C with sodium azide as preservative.

B. malayi microfilarial excretory-secretory (Bm mf ES) antigen-B. malayi microfilariae (mf) were obtained from laboratory infected jirds (Mariones unguiculatus) as described by Chenthamarakshan et alII. The mf were maintained in RPM I 1640 medium supplemented with organic acids and sugars of Grace's insect culture mediuml4 and O. I mM phenyl methyl sulphonyl floride (PMSF) at 28°C for 48 hr. The supernatant was collected, concentrated by ultramembrane filtration and dialysed against O.OIM sodium phosphate buffer (SPB) pH 7.2. The protein content was measured by Lowry's method lS and the antigen was stored at -70°C with a cocktail of proteases inhibitors as described by Reddy et at. 10.

B. malayi microfilarial soluble (mf S) antigen-B~ mf S antigen was prepared as described by Kaliraj et al

16 with few modifications. About 10 lakhs mf were washed twice with 0.05M phosphate buffer saline (PBS) pH 7.2. The mf pellet was suspended in 2ml of 0.05 M PBS containing o. I mM of ethylene diamine tetra acetic acid (EDTA) and Tosyl L-Iysine chloro­methyl ketone (TLCK) and homogenised at 4°C for 30 min. The homogenate was further sonicated (using Vibronics sonicator), 10 times each time for 30 sec at 1 min intervals and further extracted overnight by gentle shaking at 4°C. The extract was centrifuged at 13000 g for 30 min at 4°C and the supernatant collected was labelled as Bm mf S antigen. After estimation of protein 15 the antigen was stored at -70°C until further use.

Fractionation of B. malayi mf antigens by fast protein liquid chromatography (FPLC)-Bm mf antigens were fractionated by FPLC using superdex 200 HR 10/30 gel filtration column (Pharmacia Biotech, Sweden) following the manufacturer's instructions. Mf ES antigen (250 Ilgl0.5ml) and mf S antigen (300 Ilgl0.5 ml) were applied and eluted using 0.05 M PBS pH 7.2 at a flow rate of 0.5 mllmin and monitored at 280 nm. Fractions of 2 ml volume were collected and the fractions of individual protein peaks were pooled and checked for antigen activity by indirect ELISA using referral pooled filarial positive and negative sera. Thyroglobulin (669 kDa), ferritin

(440 kDa) catalase (232 kDa), aldolase (158 kDa) , human albumin (66 kDa), lysozyme (14.3 kDa) of Pharmacia Biotech, Sweden were used as molecular weight standards to calibrate the column.

Indirect enzyme linked immunosorbent assay (EL/SA)-Indirect ELISA was performed as described by Reddy et al. 10 to evaluate the whole and FPLC purified B. malayi mf antigens in detection of filarial IgG antibodies in human sera. The wells in polyvinyl chloride (PVC) microtitre plates (Dynatech, U.S.A.) coated with optimal concentrations of Bm mf S antigen (200 ng/50llllwell), Bm mf ES antigen (25ngl50llllwell) and FPLC fractions (diluted 30-fold), optimally diluted human sera (I: 100) and antihuman IgG-peroxidase conjugate were used. The results obtained by using orthophenylene diamine (OPD) as substrate were recorded as optical density (OD) values read at 490nm using Multiscan ELISA Reader (ECIL, India).

Results Fractionation of Bm mf ES and mf S antigens by

FPLC using superdex 200 HR 10/30 gel filtration column yielded 6 protein fractions each as shown in Fig. lA & B. The results of analysis of these fractions for their reactivity with referral pooled filarial and healthy normal sera are shown in Fig. 2 A& B. One of the fractions of mf ES antigen (ESF-6) and three fractions of mf S antigen (SF-2, 3 and 4) were significantly more reactive with referral pooled filarial serum than with referral pooled endemic normal serum.

The antigen fractions ESF-6 and SF-2, 3 and 4 were used to screen individual sera samples (30 from each group) of microfilaraemia, clinical filariasis and endemic normals (Table 1). While the SF-4 antigen showed only 12 (43%) microfilaraemic sera as positive, the other three antigens (ESF-6, SF-2 and 3) showed 20 (66.6%),23 (76.6%) and 21 (70%) respec­tively of these samples as positive for filarial antibodies. Of the 30 clinical filarial sera, filarial IgG antibodies were detected in 24 (80%) sera using ESF-6, in 22 (73%) sera using SF-2 antigen and in 20 (66.6%) sera using SF-3 and SF-4 antigens.

A pooled preparation of FPLC purified ESF-6, SF-2 and SF-3 antigens was evaluated in comparison with whole mf ES and mf S antigens for its diagnostic use in bancroftian filariasis based on detection of filarial IgG antibodies (Table 2). None of the 10 nonendemic normal sera samples were positive with

ALLI et al: SEROREACTIVITY OF PURIFIED B. MALAY! mf ANTIGENS 793

any of the three antigens used. While, mf ES and mf S antigens showed 23% and 30% of 30 endemic normals as positive respectively, . pooled specific FPLC fractions (ESF-6, SF-2 and SF-3) showed only 6.6% of them as positive for filarial antibodies. Using mf ES antigen 21 (70%) of "30 microfilaraemic sera were positive while both mf S antigen and pooled FPLC fractions (ESF-6, SF-2 and SF-3) showed 26 (86.6%) sera as positive. The positivity in the clinical and occult filarial sera varied broadly (55-88%) depending on the stage of infection and ' type of antigen used.

Discussion The limitations associated with parasitological

tests have necessitated the development of suitable immunodiagnostic tests for filariasis. A number of

(A) 669 440 158 66 14.3 A 280 nm kDa kDa kDn kDa kDa

0. 1.-------~~--~~----~--------~

0.08

0.06

0.04

0.02

5

(B) A 280nm

0.1

0.075

0.05

0.025

4

5

10 j15 20

669440 158 66 14.3 kDa kDa kDa kDa kDa

2

3 4

25 30

Eluant (m I)

5

o~--~~~~~--~----~----~----~ o 5 10 15 20 25 30

Eluant (ml)

Fig. ' I-FPLC fractionation of (A) B. malayi microfilarial excretory-secretory (mf ES) antigen and (B) B. malayi microfilarial phosphate buffer saline soluble (mf S) antigens. Column: Superdex 200 HR 10/30; Bed Dim: IOx300mm; Flow rate: 0.5 mI/min; Sample: 250 Ilgl500 111 (mf ES), 350 Ilgl500 111 (mf S).

filarial antigen assays have been reported and shown to be quite useful to detect actively infected cases particularly microfilaraemic5,17-19.It has also been noted that amicrofilaraemics with clinical mani­festations are usually negative for filarial antigen using most of these assays. Demonstration of antibodies against specific filarial antigens is useful in this context to detect active infection in such cases and for their better managemene. In the present study, we have evaluated the use of a cocktail preparation of specific FPLC purified B. malayi mf antigens (ESF-6, SF-2 and SF-3) to detect filarial IgG antibodies across the clinical spectrum of filariasis.

By FPLC fractionation of B. malayi mf ES and mf S antigens, it was possible to identify four active antigen fractions (ESF-6, SF-2, 3 and 4) having higher reactivity with pooled filarial serum than with pooled endemic normal serum (Fig. 2). Of these four antigen fractions, when further tested for screening individual sera, SF-4 antigen showed only 43%

(A) A (492nrn) 0.5.---------_____________ --,

0 .4 . . ... ... .. ... . . . . . . . . ... .. ... .... ...... . ....... .. . .. . . . .• . .

0 . 3 ..... .. ....... . ... ..... .. .. .. . .. . .

0.2 . .. ... ..... . .. .. ... .. .. r:: ......

0 . 1 . .ji ...... 1 .. · .. _ 0 ...I--,-.-.....1....-r----L--,--I __ .L-...,.-I_L-j

ESF- ! ESF-2 ESF-3 ESF-4 ESF-5 ESF-6

FPLC lfractions

(8) A (492nrn) 0.7 ... . ... .. . .... . . . ....... . ...... .. ........ . ......... ... . ...... .. .. .. .. .

0 . 6 ............ -

0 . 5 ...... . .... . .

0 . 4 . . .. . . ..... . .

0.3 . ... ...... .. .

0.2 ..... . . . .. .. .

SF! SF-2 SF-3 SF-4 SF-5 SF-6

FPLC fractions

Fig. 2-Reactivity of FPLC fractions Of '(A) H. malayi microfilarial excretory-secretory (mf ES) antigen and (B) B. malayi microfi1.phosphate buffer saline soluble (mf S) antigen with referral pooled filarial serum (.) and pooled endemic normals serum (D).

794 INDIAN J EXPBIOL, AUGUST 2000

microfilaraemic sera as positive, while the other three antigens (ESF-6, SF-2 and SF-3) gave 66.6-80% positivity for microfilaraemic and clinical filarial sera (Table I).

Hence a pooled preparation of ESF-6, SF-2 and SF-3 antigens was evaluated for its diagnostic use in detection of active filarial infection. The results are compared with those of whole Bm mf ES and mf S antigens (Table 2). Pooled specific FPLC purified antigens gave a sensitivity of 86.6% (in detecting filarial IgG antibodies in mf lJositive cases), which is similar to that of whole mf S antigen and higher than that of whole mf ES antigen (70%). Pooled purified antigen fractions gave higher specificity (95%) compared to the specificity obtained by using whole mf ES antigen (82.5%) or whole mf S antigen (77.5%). Further, using pooled specific FPLC

purified antigens, filarial IgG antibodies were detected in 55-88% of different grades of clinical filariasis and 65% of occult (TPE) cases (Table 2) and these results were better than using either mf ES or mf S antigen alone. ELlS A tests using a combination of antigens has been shown to achieve higher sensitivity and specificity in diagnosis of tuberculosis20

.

W. bancrofti mf soluble antigen has been used by Kaliraj et aL. 21 to detect filarial antibodies by indirect haemagglutination test (IHAT), indirect fluorescent antibody test (IFAT) and ELISA. As many as 45-65% endemic normals were reported to be positive for filarial antibodies in these tests . The saline extracts of B. malayi mf, adult and infective larvae were used in skin test to detect W. bancrofti infected cases22

• W. bancrofti mf ES antigens have been earlier used by

Table I-Detection of filarial IgG antibodies in different groups of sera using FPLC fractions of B. malay; microfilarial antigens in indirect ELISA

Sera No. No. Positive' (% positivity) Exam. using FPLC purified filarial antigen

ESF-6 SF-2 SF-3 SF-4

a) Endemic normals 30 5 (16.6) 3(10) 4(13.3) 5(16.6)

b) Micro-fiIaraemia 30 20 (66.6) 23 (76.6) 21 (70) 12 (43)

c) Clinical filariasis 30 24 (80) 22 (73 .3) 20 (66.6) 20 (66.6)

*Sera showing 0.0. of ~ mean +2 SO of 0 .0. of endemic normal sera

. Table 2-Detection of filarial IgG antibodies in different groups of sera using pooled FPLC fractions of B. malay; mf antigens

Group No. No. (%) Positive * using mf Exam. ES

antigen

I. Microfilaraemia 30 21 (70) 2. Endemic normal 30 7 (23)

(EN) 3. Non-endemic normal IO 0

(NEN) 4. Grade I Chronic 25 20 (80) 5. Grade II Chronic 20 13 (65) 6. Grade III Chronic 20 I1 (55) 7. Occult (TPE) 20 12 (60) Sensitivity

(For mf+ve Sera) 70% Specificity

(with EN & NEN sera) 82.5%

* Sera showing 0 .0. of ~ mean+2SD of 0 .0 . of endemic normal sera ** Pooled preparation ofFPLC fractions ESF .. 6, SF-2 and SF-3 TPE=Tropical pulmonary eosinophilia

PBS (S) Pooled antigen FPLC

26 (86.6) 9 (30)

o

18 (72) 13 (65) IO (50) IO (50)

86.6%

77.5%

fractions**

26 (86.6) 2 (6.6)

o

22 (88) 16 (80) 11 (55) 13 (65)

86.6%

95%

ALLI et al: SEROREACTIVITY OF PURIFIED B. MALAYI mf ANTIGENS 795

Harinath et aL 23 to detect filarial IgG antibodies with a sensitivity and specificity of 80-90%. B. malayi mf ES antigens have been reported to be useful to detect filarial infection in micro~ilaraemia, clinical and occult cases and in their long term follow up to determine the optimal period of treatment with diethyl carbamazine citrate (DEC)24. Chentha­marakshan et aL 11 used a partially purified B. malayi mf ES antigen and reported 70%, 85% and 28% of chronic filarial, microfilaraemic and endemic normals as positive for filarial antibodies. Separation of different antigen fractions from the whole antigen helps in obtaining active antigen fractions with required specificities l6

. The present study has shown that the FPLC purified B. malayi mf antigens having higher specificity are preferable to the whole mf ES or mf S antigens for detection of filarial antibodies. Further, these antigens were useful to detect active infection in different grades of clinical filariasis and establish filarial aetiology in occult (TPE) cases which intum helps in their better management.

Acknowledgement This work was supported by the Department of

Biotechnology, New Delhi and the JBTD Research scheme of MGIMS Sevagram. The authors are grateful to Dr. Sushi la Nayar, Director of this institute and Shri . Dhirubhai Mehta, Vice-President of Kasturba Health Society for their keen interest and encouragement.

References I Southgate BA, A quantitative approach to parasitological

techniques in bancroftian filariasis and its effect on epidemiological understanding. Trans Roy Soc Trop Med Hyg, 68 (1974) 177

2 Dreyer G, Saints A, Noroes J, Rocha A & Addiss D, Amicrofilaraemic carriers of adult Wuchereria bancrofti. Trans Roy Soc Trop Med Hyg, 90 (1996) 288 .

3 Harinath BC, Padigel UM, Devi KK & Reddy MYR, Diagnosis and immunomonitoring in management of lymphatic filariasis in an endemic area. J Parasitic Dis, 20(1 996) 35.

4 Katiyar JC & Murthy PK, Approaches to diagnosis of lymphatic filariasis. J Sci Indust Res, 19 (1990) I 12.

5 Weil GJ, Jain DC, Santhunam S, Malhotra A, Kumar H, Sethumadhavan KYP, Liftis F & Ghosh TK, A monoclonal antibody based enzyme immupoassay for detecting parasite antigenemia in bancroftian filariasis. J Inf Dis, 156 (1987) 350.

6 Ramzy RMR, Hafez ON, Gad AM, Faris R, Mostafa H, Buck AA & Weil GJ, Efficient assessment of filariasis endemicity by screening for filarial antigenemia in a sentinel population, Tran Roy Soc Trop Med Hyg, 88 (1994) 41 .

7 Lalitha P, Ravichandran M, Suba S, Kaliraj P, Narayanan RB & Jayaraman K, Quantitative assessment of circulating antigens in human lymphatic filariasis : A field evaluation of monoclonal antibody-based ELISA using blood collected on filter strips. Eur J Trop Med Inter Health, 3 (1998) 41 .

8 Ottesen EA, Well er PF, Lunde MN & Hussain R, Endemic filariasis on a Pacific island 11. Immunologic aspects: Immunoglobulin, complement and specific antifilarial IgG, IgM and IgE antibodies.Am J Trop Med Hyg, 31 (1982) 953.

9 Theodor JG, Kaliraj P, Jayachandran S, Jairaman K, Cloning over expression and evaluation of a recombinant fusion protein of Wuchereria bancrofti towards its application as a diagnostic agent for bancroftian filariasis. Parasitol, 106 (1993) 413.

10 Reddy MVR, Alii R, Devi KK, Narayan R, Harikrishnan R, Cheirrnaraj K & Harinath BC, Comparative evaluation of microtitre plate peroxidase and stick penicillinase enzyme immunoassay for detection of filarial antibodies using Brugia malayi microfilarial excretory-secretory antigen . J parasitic Dis, 20 (1996) 173.

I1 Chenthamarakshan Y, Reddy MVR & Harinath BC, Diagnostic potential of fractionated Brugia malayi microfilarial excretory-secretory antigen for bancroftian filariasis. Tran Roy Soc Trop Med Hyg, 90 (1996 a) 252.

12 Chenthamarakshan V, Reddy MYR & Harinath BC, Detection of filarial antigen by inhibition enzyme linked immunosorbent assay using fractionated Brugia malayi microfilarial excretory-secretory antigen . J Biosci, 21 (I 996b) 27.

13 Alikhan A, Park he KA, Reddy MVR & Harinath BC, Filari al antigen, antibody and circulating immune complexed antigen levels in bancroftian filariasis by stick ELISA Natl Med J India, 3 (1990) 265 .

14 Kharat I, Satyanarayana U, Ghirnikar SN & Harinath BC, In vitro cultivation of Wuchereria bancrofti microfilariae. Indian J Exp Biol, 18 (1980) 1245.

15 Lowry OH, Rosenbrough NJ, Farr AL & Rundall RJ, Protein measurement with the folin phenol reagent. J Bioi Chem, 193 (1951) 265 .

16 Kaliraj P, Ghirnikar SN & Harinath BC, Fractionation and evaluation of Wuchereria bancrofti microfilarial antigens in immunodiagnosis of bancroftian tilariasis. Indian J Exp Bioi, 20 (1982) 440.

17 Reddy MVR, Malhotra A & Harinath BC, Detection of circulating filarial antigen in bancroftian filariasis by Sandwich ELISA using filarial serum IgG. J He/minthol, 58 (1984) 259.

18 More SJ & Copeman DB, A highly specitic and sensitive monoclonal antibody-based ELISA for the detection of circulating antigen in bancroftian tilariasis. Trop Med Parasitol, 41 (1990) 403.

19 Chanteau S, Moulia Pelat JP & Galziou P, Og4c3 circulating antigen: A marker of infection and adult worm burden in Wuchereria bancrofti filariasis . J Inf Dis, 170 (1994) 247.

20 Bothamley GH, Udani P, Rudd R, Festenstein F & Ivanyi J, Humoral response to defined epitopes of tubercle bacilli in adult pulmonary and child tuberculosis. Eur J Clin Microbiol Infect Vis, 7 (1988) 639.

796 INDIAN J EXP BIOL, AUGUST 2000

21 Kaliraj P, Ghirnikar SN & Harinath BC, Imrnunodiagnosis of

bancroftian filariasis: Comparative efficiency of the indirect

hemagglutination test, indirect fluorescent antibody test , and

enzyme-linked immunosorbent assay done with Wuchereria

bancrofti microfilarial antigens. Am J Trop Med Hyg, 30

(1981) 982. 22 Grove DI, Cabrera BD & Valeza FS, Sensitivity and

specificity of skin reactivity to Brugia malayi and Dirofilaria

immitis antigens in bancroftian and malayan filariasis in Philippines Am J Trop Med Hyg, 26 (1977) 220.

23 Harinath BC, Malhotra A, Girnikar SN, Annadate S D, Issacs V P, & Bharati M S, Field evaluation of an enzyme linked immunosorbent assay using Wuchereria ballcrofti mf ES antigen for bancroftian filariasis. Bull WHO, 62 (1984) 941.

24 Harinath BC & Reddy MVR, Diagnosis and immuno monitoring in successful management of bancroftian filariasis J Parasitic Vis, 21 (1997) 41 .